drugset / Trial / NCT00254566

A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB)

NCT00254566

Phase 3 Completed 398 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

This trial is a research drug study to compare the effects of two antibiotics for the treatment of acute exacerbation of chronic bronchitis

Timeline

Start
2006-02
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 2 g Oral
Comparator Moxifloxacin Small molecule 400 mg

Indications